A Phase II Randomized, Multicenter, Double-Blin Trial of Two Doses of SC-49483 in Combination With ZDV versus ZDV. Subjects will be stratified by prior ZDV therapy (naive vs experienced) and viral phenotype (SI versus NSI).
Showing the most recent 10 out of 767 publications